Ventricular Fibrillation During Optical Coherence Tomography/Optical Frequency Domain Imaging - A Large Single-Center Experience.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
24 01 2020
Historique:
pubmed: 17 1 2020
medline: 21 10 2020
entrez: 17 1 2020
Statut: ppublish

Résumé

The risks of ventricular fibrillation (Vfib) associated with frequency-domain optical coherence tomography (OCT)/optical frequency domain imaging (OFDI) remain undetermined.Methods and Results:We retrospectively studied the occurrence of Vfib during OCT/OFDI for unselected indications. The frequency of Vfib and patient and procedural characteristics were investigated. A total of 4,467 OCT/OFDI pullback examinations were performed in 1,754 patients (median of 2.0 [2.0-3.0] pullbacks for 1.0 [1.0-1.3] vessels). OCT/OFDI was performed during PCI in 899 patients (51.3%). The contrast injection volume per pullback was 14.4 (11.7-17.2) mL with a flow rate of 3.4 (3.2-3.5) mL/s. Vfib occurred in 31 pullbacks (0.69%) in 30 patients (1.7%). No cases of Vfib occurred when using low-molecular-weight dextran. On multivariate analysis, contrast volume was the only independent factor for predicting Vfib (odds ratio, 1.080; 95% confidence interval, 1.008-1.158, P=0.029). The best cutoff value of contrast volume for predicting Vfib was 19.2 mL (area under the curve, 0.713, P<0.001; diagnostic accuracy, 87.1%). The present large, single-center registry study indicated that Vfib during OCT/OFDI was rare for unselected indications. Contrast injection volume used to displace blood should be limited to avoid Vfib.

Sections du résumé

BACKGROUND
The risks of ventricular fibrillation (Vfib) associated with frequency-domain optical coherence tomography (OCT)/optical frequency domain imaging (OFDI) remain undetermined.Methods and Results:We retrospectively studied the occurrence of Vfib during OCT/OFDI for unselected indications. The frequency of Vfib and patient and procedural characteristics were investigated. A total of 4,467 OCT/OFDI pullback examinations were performed in 1,754 patients (median of 2.0 [2.0-3.0] pullbacks for 1.0 [1.0-1.3] vessels). OCT/OFDI was performed during PCI in 899 patients (51.3%). The contrast injection volume per pullback was 14.4 (11.7-17.2) mL with a flow rate of 3.4 (3.2-3.5) mL/s. Vfib occurred in 31 pullbacks (0.69%) in 30 patients (1.7%). No cases of Vfib occurred when using low-molecular-weight dextran. On multivariate analysis, contrast volume was the only independent factor for predicting Vfib (odds ratio, 1.080; 95% confidence interval, 1.008-1.158, P=0.029). The best cutoff value of contrast volume for predicting Vfib was 19.2 mL (area under the curve, 0.713, P<0.001; diagnostic accuracy, 87.1%).
CONCLUSIONS
The present large, single-center registry study indicated that Vfib during OCT/OFDI was rare for unselected indications. Contrast injection volume used to displace blood should be limited to avoid Vfib.

Identifiants

pubmed: 31941850
doi: 10.1253/circj.CJ-19-0736
doi:

Substances chimiques

Contrast Media 0
Iopamidol JR13W81H44

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-185

Auteurs

Noriko Terada (N)

Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital.

Tatsuhiko Kuramochi (T)

Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital.

Tomoyo Sugiyama (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Yoshihisa Kanaji (Y)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Masahiro Hoshino (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Eisuke Usui (E)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Masao Yamaguchi (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Masahiro Hada (M)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Toru Misawa (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Yohei Sumino (Y)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Hidenori Hirano (H)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Kai Nogami (K)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Hiroki Ueno (H)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Nobutaka Wakasa (N)

Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital.

Masahiro Hosokawa (M)

Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital.

Tadashi Murai (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Tetsumin Lee (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Kazuhiko Kobashi (K)

Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital.

Tsunekazu Kakuta (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH